Direct Meds GLP-1 vs Novi: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Direct Meds GLP-1 beats Novi overall, scoring 7.9/10 vs 7.8/10. Novi is more affordable at $133/mo vs $297/mo. Choose Direct Meds GLP-1 for users wanting simple, all-inclusive pricing without insuranc. Choose Novi for cash-pay patients who want compounded semaglutide or tirzepa.
A side-by-side comparison of Direct Meds GLP-1 and Novi covering pricing, scores, medication types, insurance, and more to help you decide.
Direct Meds GLP-1
#13 of 46Straightforward compounded GLP-1 program with transparent all-inclusive pricing and no hidden fees.
Visit Direct Meds GLP-1Novi
#14 of 46Telehealth platform for compounded semaglutide and tirzepatide with month-to-month billing, six named clinicians on staff, and a 3-minute pre-approval quiz. Novi emphasizes 'all-in transparent' pricing — medication, supplies, unlimited clinician check-ins, dose adjustments, and weight-loss coaching are bundled with no add-on fees. Standard pricing is $174/mo semaglutide and $283/mo tirzepatide; promotional pricing on the offer landing drops to $99-$133/mo semaglutide and $149-$166/mo tirzepatide with $200 off advertised.
Visit Novi| Feature | Direct Meds GLP-1 | Novi |
|---|---|---|
| Our Score | 7.9/10 | 7.8/10 |
| Starting Price | $297/mo | $133/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Users wanting simple, all-inclusive pricing without insurance | Cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer |
| Ranking | #13 | #14 |
Pros & Cons Compared
Direct Meds GLP-1
Pros
- +True all-inclusive pricing — $280/mo covers medication, consultations, shipping, and pharmacy fees with no add-ons
- +Clear dose-based pricing published on their site — no surprise cost increases when titrating up
- +Fast pharmacy fulfillment: most orders ship within 48 hours of provider approval
- +Responsive customer support with live chat available during business hours
Cons
- −Compounded medications only — cannot prescribe brand-name Wegovy, Zepbound, or Ozempic
- −At $280/mo for compounded-only, it's pricier than competitors like Henry Meds ($199) or TrimRx ($179)
Novi
Pros
- +Six disclosed clinicians on staff — Daniel Funsch MD, Michael Wasef MD, Takashi Nakamura MD plus three nurse practitioners (Hastings NP, Clements NP, Vergara DNP) — more named providers than most compounded-only platforms publish
- +Month-to-month billing with no minimum commitment — cancel before any renewal date with no early-termination penalty
- +Aggressive promotional pricing on the offer landing — $99-$133/mo compounded semaglutide and $149-$166/mo compounded tirzepatide with a $200 OFF intro discount
- +Unlimited clinician check-ins, dose adjustments, and weight-loss coaching included at no additional cost
- +Free 2-day shipping; same active ingredients as Wegovy/Ozempic and Mounjaro/Zepbound (semaglutide and tirzepatide respectively)
- +100,000+ patients claimed and editorial coverage in Bloomberg, Forbes, and WebMD provide third-party signal
Cons
- −Compounded-only — no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro through the platform; no Foundayo or oral GLP-1 formats
- −Founding year, headquarters city, and corporate ownership are not publicly disclosed
- −Promotional $99-$133 pricing applies to the introductory offer landing only — standard rate after any qualifying intro period is $174-$283/mo (verify the renewal rate before enrolling)
- −Once medication is dispensed/shipped, prescriptions cannot be returned or refunded — typical for compounded telehealth but worth understanding
- −Lab requirements before prescribing are not disclosed on public pages — unclear whether baseline bloodwork is required
- −Multiple landing pages (offer-v4, offer-v6-low) show different headline prices, which can create pricing confusion before checkout
Our Verdict
Direct Meds GLP-1 edges out Novi with a score of 7.9/10 vs 7.8/10. If budget is your priority, Novi starts at $133/mo compared to Direct Meds GLP-1's $297/mo. Choose Direct Meds GLP-1 if you want: users wanting simple, all-inclusive pricing without insurance. Choose Novi if you want: cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer.